Nutriband receives china patent notice of allowance for its aversa(tm) abuse deterrent transdermal technology

Notice of allowance received from chinese national intellectual property administration (cnipa) for the patent application covering its platform aversa™ abuse deterrent transdermal technology nutriband abuse-deterrent transdermal technology consists of a proprietary aversive agent coating that employs taste aversion to deter the oral abuse of and accidental exposure to transdermal opioid and stimulant patch products aversa fentanyl has the potential to be the world's first and only abuse-deterrent opioid patch orlando, fl / accesswire / september 24, 2024 / nutriband inc. (nasdaq:ntrb)(nasdaq:ntrbw), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that it has received a notice of allowance from the chinese national intellectual property administration (cnipa) for patent application entitled, "abuse and misuse deterrent transdermal systems," which protects its aversa™ abuse deterrent transdermal technology. the aversa™ abuse deterrent technology is now covered by a broad international intellectual property portfolio with patents issued in 46 countries including the united states, europe, japan, korea, russia, mexico, canada, australia, and china.
NTRB Ratings Summary
NTRB Quant Ranking